EU urges member states to boost the use of orphan drugs - update
This article was originally published in Scrip
Executive Summary
The European Commissionhas set out a strategy for improving the recognition, diagnosis and treatment of rare diseases. The proposals include speeding up patient access to orphan drugs by better assessing their value for pricing and reimbursement purposes, and encouraging more research into new therapies.